Risk adapted chemotherapy for localised Ewings sarcoma of bone: The French EW93 study
European Journal of Cancer, 04/30/2012
Clinical Article
Gaspar N et al. – The results showing a potential benefit of a consolidation strategy including busulfan/melphalan as compared to conventional chemotherapy needed confirmation by a randomised trial and were one of the bases of the ongoing EuroEwing99.



